title: Does DNA methylation influence the effects of psychiatric drugs?
authors.affiliation: Biomolecular Research Centre, Sheffield Hallam University, Sheffield, UK.
authors.forename: Gavin P
authors.initials: GP
authors.lastname: Reynolds
authors.affiliation: Department of Neuroscience & Behavior, Medical School of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil.|Institute of Neuroscience & Behavior - INeC, Ribeirao Preto, Brazil.
authors.forename: Helene A
authors.initials: HA
authors.lastname: Fachim
mesh_terms: D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000502:physiology; D019175:DNA Methylation / Q000187:drug effects; D006801:Humans; D000071185:Pharmacogenomic Testing; D020641:Polymorphism, Single Nucleotide; D000069348:Quetiapine Fumarate / Q000494:pharmacology; D014635:Valproic Acid / Q000494:pharmacology
chemical_list: D014150:Antipsychotic Agents; D000069348:Quetiapine Fumarate; D014635:Valproic Acid
keywords: ADHD; DNA methylation; antidepressants; antipsychotics; depression; pharmacogenetics; schizophrenia; treatment response